About
Perspectum Ltd is a global medical technology company founded in 2012 as a spinout from the University of Oxford. Headquartered in Oxford, UK, with offices in the U.S. and Singapore, the company specializes in advanced digital imaging solutions for chronic systemic diseases, including liver and bile diseases, long COVID, diabetes, and cancer. Perspectum develops multiparametric MRI-based technologies that enhance the detection, diagnosis, and monitoring of these complex conditions, supporting early intervention and personalized treatment. The company’s proprietary imaging software and digital tools provide precise, quantitative data that track disease progression and treatment response, particularly in liver disease. These technologies are widely used in clinical practice and research, playing a significant role in commercial liver clinical trials worldwide. Perspectum's offerings include multiparametric MRI imaging software, digital diagnostic tools, and clinical trial support technologies, all aimed at improving diagnostic and monitoring capabilities for healthcare providers, clinicians, and researchers. With a team of over 200 employees and substantial funding, Perspectum is committed to advancing patient care through scientific innovation.
Technologies
Keywords
Company Information
-
Employees 270
-
Founded 2012
-
Annual Revenue $6000000
-
Total Funding $905133109
Location
20271 Goldenrod Lane, Germantown, Maryland, United States, 20876
